Politics
World
Stocks
Investing
Editor’s pick

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025

May 12, 2025

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Pinterest Email

previous post

Russia’s European neighbors are lifting bans on landmines. Campaigners are horrified

next post

Anti-abortion provider measure in Trump’s ‘big, beautiful bill’ could spark House GOP rebellion

You may also like

Top 5 Canadian Mining Stocks This Week: Africa...

June 7, 2025

Editor’s Picks: Marathon Project Gets Nod, Rio Tinto...

June 7, 2025

Should You Invest in Silver Bullion?

June 6, 2025

Justin Huhn: Uranium Game On — Supply “Mirage,”...

June 6, 2025

Victoria Gold-Silver Exploration Update

June 5, 2025

Scoping Study Demonstrates Low Cost Potential (Replacement)

June 5, 2025

5 Biggest Blockchain ETFs in 2025

June 4, 2025

Operational Update

June 4, 2025

Top 10 Uranium-producing Countries

June 3, 2025

Development update – Collie graphite micronising facility

June 3, 2025

Carney invites Modi to G7 summit despite strained ties between Canada and India
Kharkiv hit by ‘most powerful attack’ of entire war, mayor says, as Russia pounds Ukraine again
Your Weekly Stock Market Snapshot: What It Means for Your Investments
From Tariffs to Tech: Where Smart Money’s Moving Right Now
TSA tells Americans their Costco cards won’t fly at airport security despite love for hot dogs

Fill Out & Get More Relevant News

Your name
Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

Privacy Policy
Terms & Conditions

Disclaimer: thetradingbasics.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 thetradingbasics.com | All Rights Reserved

Politics
World
Stocks
Investing
Editor’s pick